Recent empirical contributions emphasize the importance of (potential) market size for the development of new pharmaceuticals. At the same time many scholars point out the importance of of scientific advances for the industry’s R&D activities. Against this background I analyze the relationship between (potential) market size, technological opportunities, and the number of new pharmaceuticals in...

DESCRIPTION Celexa (citalopram HBr) is an orally administered selective serotonin reuptake inhibitor (SSRI) TM with a chemical structure unrelated to that of other SSRI’s or of tricyclic, tetracyclic, or other available antidepressant agents. Citalopram HBr is a racemic bicyclic phthalane derivative designated (±)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitr...

DESCRIPTION Celexa (citalopram HBr) is an orally administered selective serotonin reuptake inhibitor (SSRI) TM with a chemical structure unrelated to that of other SSRI’s or of tricyclic, tetracyclic, or other available antidepressant agents. Citalopram HBr is a racemic bicyclic phthalane derivative designated (±)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitr...